| — | UPC_CFI_59/2025 | — | — | — | Costs only | The Munich Local Division ruled that the anti-anti-suit injunction application by Dolby International against Roku became moot after Roku voluntarily withdrew its US proceedings, declaring the application for provisional measures groundless and the earlier interim order void, with costs awarded against Roku. |
| — | UPC_CFI_755/2024 | — | — | — | PI granted | The Munich Local Division granted Avago Technologies an anti-suit/anti-enforcement injunction preventing Realtek Semiconductor from pursuing an anti-enforcement injunction in US proceedings that would block Avago from enforcing EP 1 770 912 before UPC courts, holding the UPC has jurisdiction for such provisional measures under Art. 32(1)(a)(c) UPCA. |
| 2026-03-06 | UPC_CoA_895/2025 | Court of Appeal | Application Rop 265 | Procedural | Settled | The Court of Appeal permitted Black Sheep Retail Products B.V.'s withdrawal of its appeal (UPC_CoA_895/2025 and UPC_CoA_896/2025) against the Local Division The Hague's decision of 10 October 2025 finding Black Sheep had infringed EP 2 432 351 and granting an injunction and corrective measures. The withdrawal was filed following settlement discussions, with HL Display's consent. The Court also granted Black Sheep's application for reimbursement of 60% of court fees under R. 370.9(b)(i) RoP. |
| 2025-11-20 | UPC_CFI_836/2024 | Munich CD | Revocation Action | Revocation merits | Partially revoked | The Munich Central Division partially revoked EP 4 019 790 B1 for 17 Member States in revocation proceedings brought by BAUSSMANN against Raimund Beck, upholding the patent only as amended per Auxiliary Request III (with claims 5 and 6 unchanged), and dismissing the remaining revocation claim; costs were split 70/30 in favour of the claimant. |
| 2025-05-19 | UPC_CFI_58/2025 | Munich LD | Application for provisional measures | Procedural | Costs only | Parallel Munich Local Division order to UPC_CFI_59/2025 in a related Dolby v Roku anti-anti-suit injunction application, also declaring the application moot after Roku's voluntary withdrawal, with costs awarded against Roku. |
| 2025-05-19 | UPC_CFI_59/2025 | Munich LD | Application for provisional measures | Preliminary injunction | PI denied | The Munich Local Division found the application for provisional measures by Sun Patent Trust (anti-anti-suit injunction / anti-anti-enforcement injunction against Roku) moot because Roku had already issued a cease-and-desist undertaking after the prior interim order of 28 January 2025; the application was rejected but costs were borne by Roku since it had given cause for the proceedings. |
| 2025-05-08 | ACT_2097/2024 | Dusseldorf LD | Infringement Action | Infringement merits | Infringed | Düsseldorf Local Division final decision in infringement action (with revocation counterclaim) concerning a pump patent (EP 2 778 423 B1), by Grundfos against a Chinese manufacturer (Hefei Xinhu Canned Motor Pump). The court found infringement, granted an injunction, ordered accounting/information, recall from distribution channels, and declared liability for damages from 28 February 2018. The revocation counterclaim was dismissed. Defendant bears all costs. The court addressed the admissibility of new prior art raised for the first time in the defendant's rejoinder to the revocation counterclaim, holding that such new attacks require a convincing explanation of why they could not have been included earlier. |
| 2025-04-01 | UPC_CFI_614/2024 | Munich LD | Application Rop 265 | — | Settled | The Munich Local Division confirmed withdrawal of Mann+Hummel GmbH's application for provisional measures against Sotras S.R.L. concerning EP 2 762 219 following an out-of-court settlement. The court declared the proceedings closed, agreed that no costs application would be made, and ordered 60% reimbursement of court fees to Mann+Hummel. |
| 2025-03-18 | UPC_APP_47531/2024 | Munich LD | Preliminary objection | motionName.jurisdictional | Procedural only | Procedural order from the Munich Local Division (UPC_CFI_254/2024) dismissing Roku's preliminary objection under R. 19.1(a) RoP against Sun Patent Trust's infringement action concerning EP 2 903 267. The Court ruled that: (1) alleged incompatibility of the UPCA with EU primary law is not a valid ground for preliminary objection; (2) a preliminary objection cannot be based on a violation of Art. 47(2) EU Charter or Art. 6 ECHR; (3) proof of the representative's authority for the opt-out withdrawal need not be included with the statement of claim unless challenged; and (4) for jurisdiction, only a plausible allegation of infringement is required. |
| 2025-02-14 | UPC_APP_51844/2024 | Munich LD | Preliminary objection | motionName.jurisdictional | Dismissed | The Munich Local Division rejected the preliminary objection of eight Myriad Genetics defendants challenging UPC jurisdiction and the claimant's standing to sue, holding that questions of standing and entitlement to asserted claims relate only to the merits and not to jurisdiction under Art. 32 UPCA. |
| 2024-12-09 | UPC_CFI_755/2024 | Munich LD | Application for provisional measures | Procedural | Procedural only | The Munich Local Division issued a rectification order (R. 353 RoP) correcting a factual error in the anti-suit/anti-enforcement injunction order of 9 December 2024 against Realtek Semiconductor, clarifying language about the prior license agreement between Avago's predecessor and Realtek. |
| 2024-10-22 | UPC_CFI_1/2023 | Munich CD | Application RoP262.1 (b) | Procedural | Procedural only | Munich Central Division granted Dehns' (a UPC representative firm) request for access to written pleadings and evidence in the concluded Sanofi v. Amgen revocation proceedings under R.262.1(b) RoP. The Court found that since proceedings had concluded, the balance of interests normally favours granting access to third parties with a legitimate general interest. |
| 2024-07-23 | UPC_CFI_75/2023 | Munich CD | Generic application | Procedural | Settled | Order from the Munich Central Division (Section) dated 23 July 2024 disposing of two revocation actions brought by Astellas Institute for Regenerative Medicine against Healios K.K., Riken and Osaka University. Both parties submitted a unanimous application under R. 360 RoP declaring that they concluded the actions by settlement and that the actions were devoid of purpose. The court held that parties may settle without seeking a confirmatory court decision under R. 365 RoP and declared the proceedings closed. A 20% reimbursement of court fees was granted under R. 370.9(c) RoP. Headnotes clarify that settlement-based closures are not limited to the formal R. 365 confirmation procedure. |
| 2024-07-16 | CC_586764/2023 | Munich CD | Counterclaim for revocation | Revocation merits | Revoked | The patent EP 3 666 797 B1 was revoked in its entirety for all Contracting Member States in which revocation was requested. The Main Request and all 17 Auxiliary Requests were found to lack inventive step. The defendant (patent proprietor Amgen) was ordered to bear the claimant's legal costs, agreed at EUR 1.375 million. |
| 2024-07-16 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Revocation merits | Revoked | The Munich Central Division (UPC's first-ever revocation case) revoked European patent EP 3 666 797 B1 (relating to an anti-PCSK9 antibody composition for treating hypercholesterolaemia, owned by Amgen) in its entirety for the territories of 17 UPC Contracting Member States. The patent was found to lack inventive step. All 17 auxiliary requests were also found to lack inventive step. Amgen (defendant/patent proprietor) was ordered to bear Sanofi's legal costs of EUR 1,375,000. |
| 2024-03-18 | UPC_CFI_75/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division judge-rapporteur issued an interim conference order (R. 105.5 RoP) in the revocation action brought by Astellas Institute against Healios, Riken, and Osaka University concerning EP 3 056 563. The order recorded decisions taken at the interim conference to prepare for the oral hearing, including procedural directions on evidence and scheduling. |
| 2024-03-18 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | Order following the interim conference (R. 105.5 RoP) in the revocation action by Astellas Institute for Regenerative Medicine against Healios K.K. and Osaka University (EP 3 056 564) at the Munich Section of the Central Division. The court confirmed the oral hearing would proceed as planned and admitted a second expert declaration (D21) conditionally, giving the defendant limited time to reply. |
| 2024-02-24 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued a procedural order combining two related revocation actions (Sanofi v Amgen and Regeneron v Amgen) into a single proceeding, admitted additional documents into evidence, rejected a request for an interim conference, and set the value of each action at EUR 100 million. |
| 2024-01-24 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division judge-rapporteur issued a procedural order in the Sanofi v. Amgen revocation action, declining Sanofi's request to admit supplementary expert declarations filed in response to new points raised in Amgen's rejoinder, noting that the proper course was to raise the matter at the upcoming interim conference. |
| 2023-11-20 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division refused a request by Healios K.K. and Osaka University to stay UPC revocation proceedings pending a decision by the EPO, finding no concrete near-future date for an EPO decision and holding that the interests of the parties must be weighed, with the claimant's interest in timely proceedings prevailing. |
| 2023-11-17 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued an order on a Rule 262A application by Astellas Institute for Regenerative Medicine to restrict access to a confidential annex, addressing the scope of access permitted to named individuals at the defendant entities Healios K.K. and Osaka University in the revocation action concerning EP 3 056 564. |
| 2023-10-30 | UPC_CFI_252/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division ordered Harvard College (claimant/defendant in revocation action) to provide security for legal costs under Article 69(4) UPCA and Rule 158 RoP, finding legitimate concern about enforcement of a potential cost order against NanoString Technologies Europe (a UK-based entity) in light of a preliminary injunction already imposed. |
| 2023-10-11 | UPC_CFI_75/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued a Rule 9 RoP procedural order directing parties to use the CMS and designated workflows for all submissions, clarifying that system-generated notifications constitute electronic service under Rules 278.1 and 271.6 RoP, in the revocation action by Astellas. |
| 2023-10-11 | UPC_CFI_80/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division issued a Rule 9 RoP procedural order directing parties to use the CMS and designated workflows for all submissions and limiting external correspondence to a minimum, in the revocation action by Astellas against Healios K.K. and Osaka University. |
| 2023-10-04 | UPC_CFI_252/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division ordered that a preliminary objection based on Articles 29 and 30 Brussels Ibis Regulation (lis pendens / related actions) be dealt with in the main proceedings rather than separately, for reasons of procedural economy and efficiency under Rule 20.2 RoP. |
| 2023-09-21 | UPC_CFI_75/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Munich Central Division rejected a Rule 262.1(b) request for public access to written pleadings, holding that 'education and training' does not constitute a concrete and verifiable legitimate reason, and that there is no legal basis to grant access to a letter for service. |
| 2023-09-20 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Revocation merits | Dismissed | The Munich Central Division rejected an anonymous individual's R. 262.1(b) RoP application for access to pleadings and evidence filed in Sanofi's revocation action against Amgen (EP patent, case UPC_CFI_1/2023), holding that a personal and professional interest in forming an opinion on patent validity is not a legitimate reason for granting third-party access to the case file. |
| 2023-08-24 | UPC_CFI_1/2023 | Munich CD | Preliminary objection | motionName.jurisdictional | Procedural only | The Central Division (Munich) rejected Amgen's preliminary objection challenging jurisdiction over Sanofi's revocation action, holding that the UPC Registry functions as a single receiving mailbox for the whole court and that the action was validly filed. |
| 2023-06-29 | UPC_CFI_1/2023 | Munich CD | Revocation Action | Procedural | Procedural only | The Central Division (Munich) issued a procedural order admitting Sanofi's supplementary exhibits to the Statement of Claim (filed via generic application) and confirming the date of service of the Statement for Revocation on Amgen. |